See more : Zhongfu Information Inc. (300659.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Starpharma Holdings Limited (SPL.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Starpharma Holdings Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Hill International, Inc. (HIL) Income Statement Analysis – Financial Results
- Business Coach Inc. (9562.T) Income Statement Analysis – Financial Results
- Shinnihonseiyaku Co., Ltd. (4931.T) Income Statement Analysis – Financial Results
- Baillie Gifford US Growth Trust PLC (USA.L) Income Statement Analysis – Financial Results
- Ginza Renoir Co., Ltd. (9853.T) Income Statement Analysis – Financial Results
Starpharma Holdings Limited (SPL.AX)
About Starpharma Holdings Limited
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. It offers VivaGel, a non-antibiotic therapy for the treatment and prevention of bacterial vaginosis. The company also develops VivaGel condom, an antiviral condom; and VIRALEZE, an antiviral nasal spray. In addition, it develops DEP, a dendrimer drug delivery technology, including DEP docetaxel that is in Phase 2 clinical trials, DEP cabazitaxel that is in Phase 2 clinical trial, DEP gemcitabine that is in a Phase 1/2 clinical trials, and DEP irinotecan that is in Phase 2 clinical trials for the treatment of cancer; DEP radiotheranostics for cancer treatment and diagnosis; DEP Antibody Drug Conjugates; DEP HER-2 ADC; DEP non-oncology candidates; and DEP AZD0466, which is in Phase 1/2 clinical trials to treat haematological malignancies. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.29M | 2.94M | 4.68M | 1.80M | 6.03M | 2.72M | 4.96M | 3.65M | 4.57M | 1.70M | 1.25M | 20.00K | 925.00K | 1.14M | 1.40M | 2.02M | 1.41M | 863.85K | 500.00 | 2.05M | 1.39M | 1.48M | 384.70K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 632.00K | 1.72M | 2.78M | 1.26M | 1.80M | 251.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 7.66M | 1.22M | 1.91M | 539.50K | 4.23M | 2.47M | 4.96M | 3.65M | 4.57M | 1.70M | 1.25M | 20.00K | 925.00K | 1.14M | 1.40M | 2.02M | 1.41M | 863.85K | 500.00 | 2.05M | 1.39M | 1.48M | 384.70K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 92.38% | 41.60% | 40.71% | 30.01% | 70.15% | 90.77% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 15.58M | 18.87M | 18.94M | 22.32M | 20.48M | 15.53M | 14.63M | 18.13M | 24.64M | 19.73M | 15.21M | 3.51M | 12.09M | 5.99M | 5.72M | 9.99M | 12.22M | 11.98M | 9.65M | 6.41M | 4.12M | 5.71M | 6.23M | 4.00M | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.57M | 3.77M | 3.29M | 4.02M | 2.67M | 2.50M | 2.24M | 2.94M | 4.45M | 4.39M | 4.89M | 4.15M | 4.47M | 6.23M | 6.55M | 4.13M | 5.82M | 5.33M | 3.24M | 3.28M | 2.54M | 2.47M | 2.85M | 1.52M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 3.26M | 3.57M | 2.87M | 2.52M | 3.77M | 2.43M | 1.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.57M | 7.03M | 6.86M | 6.89M | 5.18M | 6.27M | 4.67M | 3.99M | 4.45M | 4.39M | 4.89M | 4.15M | 4.47M | 6.23M | 6.55M | 4.13M | 5.82M | 5.33M | 3.24M | 3.28M | 2.54M | 2.47M | 2.85M | 1.52M | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 135.00K | 263.00K | 1.34M | 559.00K | 12.00K | 73.00K | 4.00K | 128.00K | 4.00K | 7.00K | 845.00K | 160.00K | 1.18M | 3.81M | 7.69M | 8.21M | 8.09M | 6.42M | 1.42M | 734.63K | 14.90K | 176.00K | 538.39K | -3.54M | -2.34M | -2.54M |
| Operating Expenses | 22.82M | 25.90M | 25.80M | 29.21M | 25.66M | 16.72M | 15.24M | 18.86M | 25.86M | 20.64M | 15.88M | 8.70M | 17.70M | 13.75M | 13.97M | 16.14M | 18.04M | 17.31M | 13.85M | 10.39M | 7.26M | 8.78M | 9.25M | 5.58M | -3.54M | -2.34M | -2.54M |
| Cost & Expenses | 23.45M | 27.61M | 28.58M | 30.47M | 27.46M | 16.97M | 15.24M | 18.86M | 25.86M | 20.64M | 15.88M | 8.70M | 17.70M | 13.75M | 13.97M | 16.14M | 18.04M | 17.31M | 13.85M | 10.39M | 7.26M | 8.78M | 9.25M | 5.58M | -3.54M | -2.34M | -2.54M |
| Interest Income | 1.47M | 1.27M | 217.00K | 353.00K | 523.00K | 1.06M | 1.07M | 651.00K | 2.00K | 5.00K | 7.00K | 1.57M | 1.82M | 981.00K | 699.00K | 105.00K | 297.00K | 598.92K | 571.34K | 616.04K | 640.25K | 558.67K | 945.00K | 1.08M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00K | 2.00K | 5.00K | 7.00K | 9.00K | 8.00K | 16.00K | 18.00K | 28.00K | 27.00K | 32.74K | 23.29K | 8.29K | 12.01K | 15.53K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.12M | 1.19M | 1.08M | 935.00K | 911.00K | 298.00K | 311.00K | 318.00K | 288.00K | 1.22M | 1.10M | 1.05M | 1.14M | 1.53M | 1.70M | 2.03M | 2.10M | 2.02M | 965.33K | 693.87K | 603.09K | 604.64K | 173.00K | 62.51K | 0.00 | 0.00 | 0.00 |
| EBITDA | -9.63M | -15.25M | -15.80M | -21.42M | -14.40M | -13.96M | -11.43M | -14.90M | -21.74M | -17.72M | -13.53M | -4.17M | -12.51M | -7.38M | -4.67M | -2.27M | -6.10M | -5.91M | -5.89M | -7.81M | -6.66M | -6.92M | -8.69M | -5.52M | -3.54M | -2.34M | -2.54M |
| EBITDA Ratio | -116.20% | -798.91% | -487.31% | -1,542.49% | -340.10% | -513.09% | -201.21% | -408.53% | -445.10% | -1,044.43% | -1,079.97% | -20,850.00% | -1,352.22% | -645.28% | -332.34% | -112.63% | -575.00% | -918.46% | -1,306,834.20% | -335.91% | -351.12% | -466.33% | -2,360.26% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -15.16M | -24.67M | -23.90M | -28.67M | -21.43M | -14.25M | -10.29M | -15.22M | -21.29M | -18.95M | -14.63M | -8.68M | -17.65M | -12.61M | -12.56M | -14.12M | -18.73M | -18.46M | -13.85M | -10.37M | -7.24M | -7.87M | -8.87M | -5.58M | -3.54M | -2.34M | -2.54M |
| Operating Income Ratio | -182.88% | -839.50% | -510.36% | -1,594.49% | -355.20% | -524.04% | -207.48% | -417.25% | -465.46% | -1,116.38% | -1,167.44% | -43,420.00% | -1,908.32% | -1,101.84% | -894.87% | -699.55% | -1,326.27% | -2,137.46% | -2,770,216.40% | -506.21% | -520.84% | -530.15% | -2,305.25% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 1.47M | 1.40M | 480.00K | 1.69M | 1.08M | 5.07M | 4.06M | 3.25M | -101.00K | 2.11M | 2.07M | -9.00K | 3.99M | 3.68M | 6.18M | 9.80M | 10.51M | 10.50M | 6.33M | 2.79M | 1.75M | 327.51K | 909.08K | 1.68M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -13.69M | -23.27M | -23.42M | -26.98M | -20.35M | -14.25M | -10.29M | -15.22M | -21.29M | -18.95M | -14.64M | -5.23M | -13.66M | -8.93M | -6.38M | -4.33M | -8.22M | -7.97M | -7.52M | -7.59M | -5.50M | -7.54M | -7.96M | -3.91M | -1.77M | -1.17M | -1.27M |
| Income Before Tax Ratio | -165.18% | -791.73% | -500.11% | -1,500.56% | -337.26% | -524.04% | -207.48% | -417.25% | -465.50% | -1,116.68% | -1,168.00% | -26,145.00% | -1,476.54% | -780.59% | -454.49% | -214.41% | -582.29% | -922.25% | -1,504,557.80% | -370.18% | -395.36% | -508.09% | -2,068.87% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -5.53M | -7.63M | -7.26M | -7.25M | -5.67M | -5.07M | -4.06M | -3.25M | -3.22M | 0.00 | 0.00 | 854.00K | 168.00K | 1.19M | -3.00K | -202.00K | -731.00K | -721.87K | 5.80M | -7.59M | -5.50M | -7.54M | -7.96M | -3.91M | -1.77M | -1.17M | -1.27M |
| Net Income | -8.16M | -15.64M | -16.15M | -19.73M | -14.68M | -14.25M | -10.29M | -15.22M | -21.29M | -18.95M | -14.64M | -5.23M | -13.66M | -8.93M | -6.38M | -4.13M | -7.49M | -7.24M | -7.52M | -7.59M | -5.50M | -175.06K | 53.16K | -3.91M | -1.77M | -1.17M | -1.27M |
| Net Income Ratio | -98.50% | -532.09% | -345.02% | -1,097.44% | -243.30% | -524.04% | -207.48% | -417.25% | -465.50% | -1,116.68% | -1,168.00% | -26,145.00% | -1,476.54% | -780.59% | -454.27% | -204.41% | -530.52% | -838.68% | -1,504,557.80% | -370.18% | -395.36% | -11.79% | 13.82% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 | -0.06 | -0.05 | -0.02 | -0.05 | -0.04 | -0.03 | -0.02 | -0.04 | -0.04 | -0.06 | -0.07 | -0.05 | 0.00 | -0.09 | -0.05 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 | -0.04 | -0.06 | -0.06 | -0.05 | -0.02 | -0.05 | -0.04 | -0.03 | -0.02 | -0.04 | -0.04 | -0.06 | -0.07 | -0.05 | 0.00 | -0.09 | -0.05 | -0.02 | -0.01 | -0.01 |
| Weighted Avg Shares Out | 411.43M | 390.96M | 403.85M | 394.64M | 366.95M | 356.35M | 370.14M | 368.16M | 345.04M | 310.14M | 284.41M | 283.28M | 267.65M | 242.56M | 225.55M | 184.08M | 177.99M | 161.67M | 132.30M | 111.24M | 102.17M | 88.90M | 88.90M | 82.46M | 88.90M | 88.90M | 88.90M |
| Weighted Avg Shares Out (Dil) | 411.43M | 409.04M | 406.90M | 396.88M | 372.23M | 371.29M | 370.14M | 368.16M | 345.04M | 310.14M | 284.41M | 283.28M | 267.65M | 242.56M | 225.55M | 184.08M | 177.99M | 161.67M | 132.30M | 111.24M | 102.17M | 88.90M | 88.90M | 82.46M | 88.90M | 88.90M | 88.90M |
Source: https://incomestatements.info
Category: Stock Reports